Article citationsMore>>

Orchard, T.J., Temprosa, M., Goldberg, R., Haffner, S., Ratner, R., Marcovina, S. and Fowler, S. (2005) The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: The diabetes prevention program randomized trial. Annuals of Internal Medicine, 142, 611-619. doi:10.7326/0003-4819-142-8-200504190-00009

has been cited by the following article:

• TITLE: The “metabolic syndrome index”: A novel, comprehensive method for evaluating the efficacy of diabetes prevention programs

  AUTHORS: Hongbin Jin, Daniel C. Benyshek

  KEYWORDS: Evaluation; Metabolic Syndrome; Type 2 Diabetes Prevention; T2D

  JOURNAL NAME: Journal of Diabetes Mellitus, Vol.3 No.2, May 22, 2013

  ABSTRACT: A myriad of diabetes prevention programs are carried out worldwide to fight against the current type 2 diabetes (T2D) pandemic. The lack of a unified criterion for evaluating the efficacy of T2D prevention programs, however, makes the interpretation of prevention program results difficult, and hinders clear and direct comparisons of different prevention programs. Metabolic syndrome is a strong indicator for diabetes and its complications, holding great promise to become the basis of an intervention evaluation method. The Metabolic Syndrome Index (MSI), proposed here, quantifies the metabolic risk for developing T2D and its complications. The MSI is a novel scale for evaluating the efficacy of diabetes prevention programs because it is a systematic, comprehensive, and stable indicator that reflects the metabolic risk reduction for diabetes and its complications at multiple levels and dimensions.